Build an Inve Case for DCGO → Read the full call → US$ mn · quarterly
DocGo (DCGO) earnings
DocGo earnings: last reported Mon, 17 Aug 2026, for the quarter ended Jun 2026.
DocGo earnings callsDocGo earnings calls (DCGO)
Latest concall · Q2 2026 · call held call held 17 Aug 2026
DocGo Q2 FY26 — Hicuity Health Acquisition and Strong Organic Growth
What went well
- Signed definitive agreement to acquire Hicuity Health, a virtual care provider with $65 million in TTM revenue and $4.5 million in adjusted EBITDA.
- Achieved record volumes across key business verticals: U.S. medical transportation up 15% YoY, health care in the home up 26% YoY, mobile phlebotomy up 20% YoY, cardiac and remote patient monitoring up 13% YoY, and virtual care and lab orders up 58% YoY.
- Non-migrant revenue increased 19% YoY in Q2 2026, with organic growth (excluding migrant and SteadyMD) at 5% YoY.
What to watch
- Adjusted EBITDA loss for Q2 2026 was negative $6.3 million, wider than original expectations for the full year.
- Full-year adjusted EBITDA loss guidance widened to $17 million to $22 million from $5 million to $10 million previously.
Performance −71.0% 1Y
1Y: $1.38 on 29 Sept 2025 → $0.4. High $1.49 (21 Oct 2025), low $0.34 (24 Sept 2026).
Quarterly results
Q2 FY26: revenue down 8.7%, net profit down 41.8% against the same quarter last year.
| Line item | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 139 | 121 | 96 | 80 | 71 −49% | 75 −38% | 76 −21% | 73 −9% |
| EBITDA | 10 | -7 | -14 | -17 | -42 −514% | -105 −1299% | -19 −34% | -18 −3% |
| Net profit | 5 | -3 | -9 | -11 | -28 −605% | -134 −4009% | -15 −57% | -16 −42% |
How to read this
US$ million, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Balance sheet
| Year ending | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Equity capital | $172 | $10.0K | $10.2K | $10.4K | $10.2K | $9.9K |
| Reserves | -$87.30M | -$63.56M | -$28.97M | -$21.39M | -$1.40M | -$183.80M |
| Total liabilities | $33.23M | $82.55M | $114.35M | $185.28M | $140.44M | $91.23M |
| Fixed assets | $9.11M | $12.73M | $21.26M | $16.84M | $14.88M | $14.56M |
| Total assets | $100.17M | $309.60M | $393.28M | $490.45M | $455.62M | $217.10M |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Insider filings
14 filings between Dec 12, 2025 and May 12, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$15.3K
1 sale by 1 insider
Compensation
not trading decisions- 8
- Award — granted as compensation
- 5
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Tendler Ely D | — | $15.3K | Dec 15, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | Bienstock Lee Chief Executive Officer | Tax withheld | 15,644 | $9.2K |
| Mar 30, 2026 | Bienstock Lee Chief Executive Officer | Tax withheld | 18,811 | $10.7K |
| Dec 15, 2025 | Sugrue Stephen Chief Compliance Officer | Tax withheld | 35,968 | $32.7K |
| Dec 15, 2025 | Tendler Ely D General Counsel and Secretary | Sale | 16,850 | $15.3K |
| Dec 15, 2025 | ROSENBERG NORMAN CFO and Treasurer | Tax withheld | 65,774 | $59.9K |
| Dec 15, 2025 | Bienstock Lee Chief Executive Officer | Tax withheld | 214,131 | $194.9K |
| Dec 12, 2025 | TRAVERS JAMES M Director | Award | 150,000 | $0 |
| Dec 12, 2025 | ROSENBERG NORMAN CFO and Treasurer | Award | 429,405 | $0 |
| Dec 12, 2025 | Tendler Ely D General Counsel and Secretary | Award | 100,000 | $0 |
| Dec 12, 2025 | Leite Etalvina Director | Award | 150,000 | $0 |
| Dec 12, 2025 | Sugrue Stephen Chief Compliance Officer | Award | 321,055 | $0 |
| Dec 12, 2025 | Smedra Ira Director | Award | 150,000 | $0 |
| Dec 12, 2025 | Bienstock Lee Chief Executive Officer | Award | 1,113,495 | $0 |
| Dec 12, 2025 | Burdiek Michael J Director | Award | 150,000 | $0 |
| Sep 10, 2025 | Klasko Stephen K. M.D. Director | Award | 100,000 | $0 |
| Jul 2, 2025 | Bienstock Lee Chief Executive Officer | Tax withheld | 18,597 | $28.3K |
| Jul 2, 2025 | ROSENBERG NORMAN CFO and Treasurer | Tax withheld | 11,332 | $17.2K |
| Jul 2, 2025 | Sugrue Stephen Chief Compliance Officer | Tax withheld | 5,813 | $8.8K |
| May 23, 2025 | Burdiek Michael J Director | Purchase | 10,000 | $13.3K |
| May 14, 2025 | Bienstock Lee Chief Executive Officer | Purchase | 15,000 | $23.1K |
| May 14, 2025 | ROSENBERG NORMAN CFO and Treasurer | Purchase | 15,000 | $22.1K |
| May 14, 2025 | Klasko Stephen K. M.D. Director | Purchase | 15,000 | $22.4K |
| May 14, 2025 | Sugrue Stephen Chief Compliance Officer | Purchase | 10,000 | $14.4K |
| Apr 2, 2025 | Sugrue Stephen Chief Compliance Officer | Tax withheld | 5,614 | $15.0K |
| Apr 2, 2025 | Bienstock Lee Chief Executive Officer | Tax withheld | 18,598 | $49.8K |
| Apr 2, 2025 | ROSENBERG NORMAN CFO and Treasurer | Tax withheld | 8,004 | $21.5K |
| Mar 31, 2025 | Bienstock Lee Chief Executive Officer | Tax withheld | 18,742 | $49.5K |
| Mar 7, 2025 | Bienstock Lee Chief Executive Officer | Award | 465,116 | $0 |
| Mar 7, 2025 | Bienstock Lee Chief Executive Officer | Tax withheld | 59,360 | $179.9K |
| Mar 7, 2025 | ROSENBERG NORMAN CFO and Treasurer | Award | 170,543 | $0 |
| Mar 7, 2025 | ROSENBERG NORMAN CFO and Treasurer | Tax withheld | 15,370 | $46.6K |
| Mar 7, 2025 | Sugrue Stephen Chief Compliance Officer | Award | 77,520 | $0 |
| Mar 7, 2025 | Sugrue Stephen Chief Compliance Officer | Tax withheld | 7,789 | $23.6K |
| Jan 2, 2025 | Bienstock Lee Chief Executive Officer | Tax withheld | 18,598 | $78.7K |
| Jan 2, 2025 | ROSENBERG NORMAN CFO and Treasurer | Tax withheld | 9,180 | $38.8K |
| Jan 2, 2025 | Sugrue Stephen Chief Compliance Officer | Tax withheld | 4,708 | $19.9K |
| Dec 17, 2024 | Leite Etalvina Director | Sale | 16,500 | $71.6K |
| Dec 16, 2024 | Tendler Ely D General Counsel and Secretary | Sale | 23,088 | $102.5K |
| Dec 13, 2024 | Leite Etalvina Director | Award | 34,965 | $0 |
| Dec 13, 2024 | Bienstock Lee Chief Executive Officer | Tax withheld | 86,236 | $361.3K |
| Dec 13, 2024 | ROSENBERG NORMAN CFO and Treasurer | Tax withheld | 19,213 | $80.5K |
| Dec 13, 2024 | Sugrue Stephen Chief Compliance Officer | Tax withheld | 8,734 | $36.6K |
| Dec 13, 2024 | Burdiek Michael J Director | Award | 34,965 | $0 |
| Dec 13, 2024 | Smedra Ira Director | Award | 34,965 | $0 |
| Dec 13, 2024 | TRAVERS JAMES M Director | Award | 34,965 | $0 |
| Dec 12, 2024 | Sugrue Stephen Chief Compliance Officer | Award | 107,399 | $0 |
| Dec 12, 2024 | ROSENBERG NORMAN CFO and Treasurer | Award | 346,062 | $0 |
| Dec 12, 2024 | Tendler Ely D General Counsel and Secretary | Award | 35,800 | $0 |
| Dec 12, 2024 | Bienstock Lee Chief Executive Officer | Award | 536,993 | $0 |
| Oct 4, 2024 | Bienstock Lee Chief Executive Officer | Tax withheld | 18,598 | $62.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.